Conversely, VIP binding to the VPAC2 receptor upregulates IL-5 and IL-13, promotes the accumulation of eosinophils, and induces the conversion of the Th2 phenotype, altering the immune response to allergy and inflammation [45, 46]. This evidence concerns the gene VIP and allergic disease.